Acute Myocardial Infarction during the Subacute Phase of Refractory and Incomplete Kawasaki Disease in a Five-year-old Boy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Kawasaki disease (KD) is an acute, systemic vasculitis of childhood. The early mortality of KD results from coronary complications, mainly aneurysmal thrombosis with myocardial infarction, and the subacute phase of KD has the highest risk of mortality. Although there have been reports of ischemic heart disease as late cardiologic sequelae of KD in young adults, acute myocardial infarction caused by coronary complications in the subacute phase of KD is rare. We experienced one pediatric patient who developed coronary artery aneurysm and acute myocardiac infarction (AMI) during the subacute phase of incomplete and intravenous immunoglobulin (IVIG)-nonresponsive KD. The patient was given a good prognosis due to close monitoring and early recognition of AMI. Physicians should carefully monitor KD patients who do not respond to initial IVIG therapy and who show progressive coronary artery dilatation. If such a patient complaints of chest pain and the ECG shows hyperacute T waves, the physician should suspect development of AMI.
Abstract
Kawasaki disease (KD) is an acute, systemic vasculitis of childhood. The early mortality of KD results from coronary complications, mainly aneurysmal thrombosis with myocardial infarction, and the subacute phase of KD has the highest risk of mortality. Although there have been reports of ischemic heart disease as late cardiologic sequelae of KD in young adults, acute myocardial infarction caused by coronary complications in the subacute phase of KD is rare. We experienced one pediatric patient who developed coronary artery aneurysm and acute myocardiac infarction (AMI) during the subacute phase of incomplete and intravenous immunoglobulin (IVIG)-nonresponsive KD. The patient was given a good prognosis due to close monitoring and early recognition of AMI. Physicians should carefully monitor KD patients who do not respond to initial IVIG therapy and who show progressive coronary artery dilatation. If such a patient complaints of chest pain and the ECG shows hyperacute T waves, the physician should suspect development of AMI.
참고문헌 (20)
- Sonobe T, "Prevalence of coronary artery abnormality in incomplete Kawasaki disease", Pediatr Int, 49, pp.421~426 (2007)
- Manlhiot C, "Kawasaki disease at the extremes of the age spectrum", Pediatrics, 124, pp.e410~e415 (2009)
- Newburger JW, "Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endo- carditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association", Pediatrics, 114, pp.1708~1733 (2004)
- Burns JC, "Kawasaki syndrome", Lancet, 364, pp.533~544 (2004)
- Kato H, "Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases", J Pediatr, 108, pp.923~927 (1986)
- Sudo D, "Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan", Eur J Pediatr, 171, pp.651~656 (2012)
- Giannouli G, "Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete kawasaki disease during a 10-year period", Pediatr Cardiol, 34, pp.1476~1481 (2013)
- Terai M, "Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose", J Pediatr, 131, pp.888~893 (1997)
- Ghelani SJ, "Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines", Pediatr Cardiol, 33, pp.1097~1103 (2012)
- Burns JC, "Intravenous gamma globulin treatment and retreatment in Kawasaki disease. US", Canadian Kawasaki Syndrome Study Group, 1998, pp.17, 1144~1148
- Hashino K, "Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy", Pediatr Int, 43, pp.211~217 (2001)
- Ogata S, "The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immuneglobulin and steroid pulse therapy", J Cardiol, 53, pp.15~19 (2009)
- Teraguchi M, "Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease:a prospective study", Pediatr Cardiol, 34, pp.959~963 (2013)
- Jibiki T, "Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease", Pediatr Int, 53, pp.729~735 (2011)
- Lee SY, "Acute myocardial infarction in young patient probably due to Kawasaki disease", Korean Circ J, 31, pp.119~124 (2001)
- Kim WJ, "Giant coronary aneurysm with stenosis and thrombus formation due to Kawasaki Disease: Treatment with graft stent", J Korean Pediatr Cardiol Soc, 9, pp.394~399 (2005)
- Choi YS, "Medicolegal Investigation of Kawasaki Disease: Three cases of sudden death by coronary artery lesions", Korean J Leg Med, 27, pp.39~44 (2003)
- Kliegman RM, "Nelson textbook of pediatrics", pp.862~867 (2011), Saunders
- Paredes N, "Management of myocardial infarction in children with Kawasaki disease", Blood Coagul Fibrinolysis, 21, pp.620~631 (2010)
- Ishii M, "Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease", Pediatrics Int, 43, pp.558~562 (2001)